Israeli lymphoma doctors specialize in CAR-T cell therapy, particularly for refractory and recurrent blood cancers. Experts at JCI-accredited centers like Sourasky Medical Center (Ichilov) perform these advanced treatments. They use modified immune cells to target lymphoma directly, offering options when standard therapies fail.
- Specialized leadership. Dr. Fredi Aviv leads the Hemato-Oncology Institute at Sourasky Medical Center.
- Pediatric expertise. Dr. Ronit El Hasid leads pediatric oncohematology and trained in Los Angeles.
- Extensive research. Dr. Ofer Merimsky collaborates on research with the Weizmann Institute of Science.
- Transplant volume. Dr. Ron Ram has performed hundreds of stem cell transplants for hematologic cancers.
Bookimed Expert Insight: Israeli specialists often hold triple board certifications in internal medicine, hematology, and oncology. Dr. Ron Ram at Sourasky Medical Center is one such expert. This broad training means they can manage both the lymphoma and any complex side effects from intensive CAR-T therapy.
Patient Consensus: Patients are often surprised by the detailed explanations doctors provide about how modified cells work. Those treated for complex lymphomas noticed that specialists coordiante closely with transplant teams to ensure the best possible timing for treatment.
